{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:34:37Z","timestamp":1769733277765,"version":"3.49.0"},"reference-count":248,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR134220"],"award-info":[{"award-number":["NIHR134220"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>\nPeople with suspected prostate cancer are usually offered either a local anaesthetic transrectal ultrasound-guided prostate biopsy or a general anaesthetic transperineal prostate biopsy. Transperineal prostate biopsy is often carried out under general anaesthetic due to pain caused by the procedure. However, recent studies suggest that performing local anaesthetic transperineal prostate biopsy may better identify cancer in particular regions of the prostate and reduce infection rates, while being carried out in an outpatient setting. Devices to assist with freehand methods of local anaesthetic transperineal prostate may also help practitioners performing prostate biopsies.<\/jats:p>\n<\/jats:sec>\nObjectives<\/jats:title>\nTo evaluate the clinical effectiveness and cost-effectiveness of local anaesthetic transperineal prostate compared to local anaesthetic transrectal ultrasound-guided prostate and general anaesthetic transperineal prostate biopsy for people with suspected prostate cancer, and local anaesthetic transperineal prostate with specific freehand devices in comparison with local anaesthetic transrectal ultrasound-guided prostate and transperineal prostate biopsy conducted with a grid and stepping device conducted under local or general anaesthetic.<\/jats:p>\n<\/jats:sec>\nData sources and methods<\/jats:title>\nWe conducted a systematic review of studies comparing the diagnostic yield and clinical effectiveness of different methods for performing prostate biopsies. We used pairwise and network meta-analyses to pool evidence on cancer detection rates and structured narrative synthesis for other outcomes. For the economic evaluation, we reviewed published and submitted evidence and developed a model to assess the cost-effectiveness of the different biopsy methods.<\/jats:p>\n<\/jats:sec>\nResults<\/jats:title>\nWe included 19 comparative studies (6 randomised controlled trials and 13 observational comparative studies) and 4 single-arm studies of freehand devices. There were no statistically significant differences in cancer detection rates for local anaesthetic transperineal prostate (any method) compared to local anaesthetic transrectal ultrasound-guided prostate (relative risk 1.00, 95% confidence interval 0.85 to 1.18) (n<\/jats:italic> = 5 randomised controlled trials), as was the case for local anaesthetic transperineal prostate with a freehand device compared to local anaesthetic transrectal ultrasound-guided prostate (relative risk 1.40, 95% confidence interval 0.96 to 2.04) (n<\/jats:italic> = 1 randomised controlled trial). Results of meta-analyses of observational studies were similar. The economic analysis indicated that local anaesthetic transperineal prostate is likely to be cost-effective compared with local anaesthetic transrectal ultrasound-guided prostate (incremental cost below \u00a320,000 per quality-adjusted life-year gained) and less costly and no less effective than general anaesthetic transperineal prostate. local anaesthetic transperineal prostate with a freehand device is likely to be the most cost-effective strategy: incremental cost versus local anaesthetic transrectal ultrasound-guided prostate of \u00a3743 per quality-adjusted life-year for people with magnetic resonance imaging Likert score of 3 or more at first biopsy.<\/jats:p>\n<\/jats:sec>\nLimitations<\/jats:title>\nThere is limited evidence for efficacy in detecting clinically significant prostate cancer. There is comparative evidence for the PrecisionPoint\u2122 Transperineal Access System (BXTAccelyon Ltd, Burnham, UK) but limited or no evidence for the other freehand devices. Evidence for other outcomes is sparse. The cost-effectiveness results are sensitive to uncertainty over cancer detection rates, complication rates and the numbers of core samples taken with the different biopsy methods and the costs of processing them.<\/jats:p>\n<\/jats:sec>\nConclusions<\/jats:title>\nTransperineal prostate biopsy under local anaesthetic is equally efficient at detecting prostate cancer as transrectal ultrasound-guided prostate biopsy under local anaesthetic but it may be better with a freehand device. local anaesthetic transperineal prostate is associated with urinary retention type complications, whereas local anaesthetic transrectal ultrasound-guided prostate has a higher infection rate. local anaesthetic transperineal prostate biopsy with a freehand device appears to meet conventional levels of costeffectiveness compared with local anaesthetic transrectal ultrasound-guided prostate.<\/jats:p>\n<\/jats:sec>\nStudy registration<\/jats:title>\nThis study is registered as PROSPERO CRD42021266443.<\/jats:p>\n<\/jats:sec>\nFunding<\/jats:title>\nThis award was funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme (NIHR award ref: NIHR134220) and is published in full in Health Technology Assessment<\/jats:italic> Vol. 28, No. 60. See the NIHR Funding and Awards website for further award information.<\/jats:p>\n<\/jats:sec>","DOI":"10.3310\/zktw8214","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:34:21Z","timestamp":1728041661000},"page":"1-213","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-4513","authenticated-orcid":true,"given":"In\u00eas","family":"Souto-Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-9149","authenticated-orcid":true,"given":"Lois","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3998-6669","authenticated-orcid":true,"given":"Emma","family":"Maund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-8046","authenticated-orcid":true,"given":"David","family":"Alexander Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-1624","authenticated-orcid":true,"given":"Joanne","family":"Lord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-996X","authenticated-orcid":true,"given":"Joanna","family":"Picot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-4330","authenticated-orcid":true,"given":"Jonathan","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2024,10]]},"reference":[{"key":"key2024100416541800_ref1-bib1","volume-title":"Prostate Cancer Statistics: Prostate Cancer Incidence","author":"Cancer Research UK","year":"2017"},{"key":"key2024100416541800_ref2-bib2","volume-title":"Lifetime Risk of Prostate Cancer","author":"Cancer Research UK","year":"2018"},{"key":"key2024100416541800_ref3-bib3","volume-title":"Prostate Cancer Incidence Statistics","author":"Cancer Research UK"},{"key":"key2024100416541800_ref4-bib4","volume-title":"Prostate Cancer Risk","author":"Cancer Research UK"},{"key":"key2024100416541800_ref5-bib5","volume-title":"Cancer Registration Statistics, England: Final Release, 2018: Public Health England","author":"Public Health England","year":"2020"},{"key":"key2024100416541800_ref6-bib6","volume-title":"Cancer Registration Statistics: Cancer Mortality in England, 2018: Public Health England","author":"Public Health England","year":"2020"},{"key":"key2024100416541800_ref7-bib7","volume-title":"Suspected Cancer: Recognition and Referral","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"key2024100416541800_ref8-bib8","volume-title":"Prostate Cancer: Diagnosis and Management. NG131","author":"National Institute for Health and Care Excellence","year":"2019"},{"key":"key2024100416541800_ref9-bib9","volume-title":"Prostate Cancer: Diagnosis and Management [D] Evidence Review for Diagnosing and Identifying Clinically Significant Prostate Cancer","author":"National Institute for Health and Care Excellence","year":"2019"},{"key":"key2024100416541800_ref10-bib10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"key2024100416541800_ref11-bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, Version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref12-bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref14-bib14","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"key2024100416541800_ref17-bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"key2024100416541800_ref18-bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N Engl J Med"},{"key":"key2024100416541800_ref19-bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"key2024100416541800_ref20-bib20","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key2024100416541800_ref21-bib21","volume-title":"Joanna Briggs Institute Reviewer\u2019s Manual","author":"Moola","year":"2017"},{"key":"key2024100416541800_ref22-bib22","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"key2024100416541800_ref23-bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","author":"Owen","year":"2019","journal-title":"Res Synth Methods"},{"key":"key2024100416541800_ref24-bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4081\/aiua.2014.4.284","article-title":"Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: a comparative evaluation at the same institution","volume":"86","author":"Cerruto","year":"2014","journal-title":"Arch Ital Urol Androl"},{"key":"key2024100416541800_ref25-bib25","doi-asserted-by":"crossref","first-page":"16089","DOI":"10.1038\/srep16089","article-title":"Comparison between ultrasound guided transperineal and transrectal prostate biopsy: a prospective, randomized and controlled trial","volume":"5","author":"Guo","year":"2015","journal-title":"Sci Rep"},{"key":"key2024100416541800_ref26-bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2007.09.029","article-title":"Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy","volume":"71","author":"Hara","year":"2008","journal-title":"Urology"},{"key":"key2024100416541800_ref27-bib27","doi-asserted-by":"crossref","first-page":"S1405","DOI":"10.1016\/S0302-2838(21)01372-5","article-title":"P0999 Prostate cancer detection, tolerability and safety of transperineal prostate biopsy under local-anaesthesia versus standard transrectal biopsy in biopsy-na\u00efve men: a pragmatic, parallel group, randomized-controlled study","volume":"79","author":"Lam","year":"2021","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref28-bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.pcan.4500985","article-title":"A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy","volume":"11","author":"Takenaka","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref30-bib30","first-page":"8","article-title":"Comparing outcomes of transperineal to transrectal prostate biopsies performed under local anaesthesia","volume":"1","author":"Chen","year":"2021","journal-title":"BJUI Compass"},{"key":"key2024100416541800_ref31-bib31","first-page":"e307","article-title":"Is transperineal prostate biopsy the emerging standard? a prospective comparison on outcomes of transperineal versus transrectal prostate biopsies","volume":"203","author":"Chen","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref32-bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0090-4295(02)02551-7","article-title":"Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy","volume":"61","author":"Emiliozzi","year":"2003","journal-title":"Urology"},{"key":"key2024100416541800_ref33-bib33","doi-asserted-by":"crossref","first-page":"e2315","DOI":"10.1016\/S2666-1683(20)34175-6","article-title":"Transrectal vs. transperineal prostate biopsy under local anaesthesia: prospective comparative analysis of cancer detection, safety and tolerability using patient-reported outcome measures at a single centre","volume":"19","author":"Hung","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref34-bib34","first-page":"A212","article-title":"Outcomes of local anaesthetic freehand transperineal biopsies in the outpatient setting: how does this compare to conventional biopsy methods?","volume":"32","author":"Kum","year":"2018","journal-title":"J Endourol"},{"key":"key2024100416541800_ref35-bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bju.14620","article-title":"Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting","volume":"125","author":"Kum","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref36-bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/20514158211024075","article-title":"Comparing tolerability of local anaesthetic transperineal and transrectal prostate biopsies","volume":"16","author":"Starmer","year":"2021","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref38-bib38","first-page":"959","article-title":"Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection","volume":"12","author":"Watanabe","year":"2005","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"key2024100416541800_ref39-bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.urology.2010.08.048","article-title":"Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate?","volume":"77","author":"Abdollah","year":"2011","journal-title":"Urology"},{"key":"key2024100416541800_ref40-bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4103\/aja.aja_16_19","article-title":"Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: a propensity score-matched study","volume":"21","author":"Jiang","year":"2019","journal-title":"Asian J Androl"},{"key":"key2024100416541800_ref41-bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/end.2020.1086","article-title":"Free-hand transperineal prostate biopsy under local anesthesia in the office without antibiotic prophylaxis: experience with 304 cases","volume":"35","author":"Szabo","year":"2021","journal-title":"J Endourol"},{"key":"key2024100416541800_ref42-bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41391-019-0155-0","article-title":"Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: a prospective randomised controlled trial","volume":"23","author":"Lv","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref43-bib43","first-page":"S306","article-title":"Transperineal ultrasound-guided multiple core biopsy using template for patients with one or more previous negative biopsies: comparison with systematic 10-core biopsy","volume":"80","author":"Takuma","year":"2012","journal-title":"Urology"},{"key":"key2024100416541800_ref44-bib44","doi-asserted-by":"crossref","first-page":"S1245","DOI":"10.1016\/S0302-2838(21)01262-8","article-title":"P0888: switching from sedation to local anaesthetic transperineal prostate biopsies: a cost-benefit analysis","volume":"79","author":"Walters","year":"2021","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref45-bib45","first-page":"87","article-title":"Transperineal prostate biopsy under local anaesthetic is ready for prime time \u2013 a comparison between general anaesthetic procedure for accuracy, tolerability and complications","volume":"125","author":"Rij","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref46-bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/2051415820932773","article-title":"Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: the CAMbridge PROstate Biopsy DevicE (CamPROBE) study","volume":"13","author":"Gnanapragasam","year":"2020","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref47-bib47","doi-asserted-by":"crossref","first-page":"e2307","DOI":"10.1016\/S2666-1683(20)34168-9","article-title":"Short term outcomes of zero-antibiotic co-axial needle-guided transperineal prostate biopsy under local anaesthesia (CTB): a prospective study","volume":"19","author":"Lau","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref48-bib48","first-page":"40","article-title":"Safety of zero-antibiotic co-axial needleguided transperineal prostate biopsy (TPB) under local anaesthesia: a prospective cohort study of 200 patients","volume":"12","author":"Yamamoto","year":"2019","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref49-bib49","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1016\/S2666-1683(20)34196-3","article-title":"Office-based transperineal prostate biopsies under local anaesthesia with cognitive registration: technique, immediate patient perception and cancer detection \u2013 a prospective study","volume":"19","author":"Yamamoto","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref50-bib50","volume-title":"Checklist for Cohort Studies (The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews).","author":"The Joanna Briggs Institute","year":"2017"},{"key":"key2024100416541800_ref51-bib51","volume-title":"Checklist for Case Series (The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews).","author":"The Joanna Briggs Institute","year":"2017"},{"key":"key2024100416541800_ref52-bib52","volume-title":"A Study That Aims to Find Out in the NHS What Is the Best Way to Take a Prostate Biopsy to Determine if a Man has Prostate Cancer (the TRANSLATE Trial)","author":"ISRCTN","year":"2021"},{"key":"key2024100416541800_ref53-bib53","volume-title":"TRANSLATE Trial Website Oxford: Oxford Clinical Trials Research Unit","author":"Oxford Clinical Trials Research Unit","year":"2021"},{"key":"key2024100416541800_ref54-bib54","author":"Bryant","year":"2021"},{"key":"key2024100416541800_ref55-bib55","volume-title":"Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications","author":"Albany Medical","year":"2021"},{"key":"key2024100416541800_ref56-bib56","volume-title":"Evaluation of Transperineal Biopsy under Local Anesthesia","author":"NCT","year":"2021"},{"key":"key2024100416541800_ref57-bib57","volume-title":"Randomized Trial Comparing Transperineal vs. Transrectal MRI-Targeted Prostate Biopsy","author":"NCT","year":"2021"},{"key":"key2024100416541800_ref58-bib58","volume-title":"Transperineal Prostate Biopsy Under Local Anaesthetic Compared to General Anaesthetic for Men with Suspected Prostate Cancer","author":"ANZCTR","year":"2020"},{"key":"key2024100416541800_ref59-bib59","volume-title":"Transperineal Biopsy for Diagnosing Prostate Cancer; Project Documents","author":"National Institute for Health and Care Excellence","year":"2022"},{"key":"key2024100416541800_ref60-bib60","volume-title":"Strings Attached: CADTH Database Search Filters.","year":"2021"},{"key":"key2024100416541800_ref61-bib61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jval.2014.01.003","article-title":"Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report","volume":"17","author":"Caro","year":"2014","journal-title":"Value Health"},{"key":"key2024100416541800_ref62-bib62","doi-asserted-by":"crossref","first-page":"iiiix1","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref63-bib63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s41669-021-00277-4","article-title":"Economic evaluation of transperineal versus transrectal devices for local anaesthetic prostate biopsies","volume":"5","author":"Wilson","year":"2021","journal-title":"PharmacoEcon Open"},{"key":"key2024100416541800_ref64-bib64","first-page":"1","article-title":"Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study","volume":"22","author":"Brown","year":"2018","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref65-bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2017.08.018","article-title":"Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS)","volume":"73","author":"Faria","year":"2018","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref66-bib66","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006576.pub2","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","author":"Zani","year":"2011","journal-title":"Cochrane Database Syst Rev 2011"},{"key":"key2024100416541800_ref69-bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.euo.2019.04.008","article-title":"Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort","volume":"3","author":"Blazevski","year":"2020","journal-title":"Eur Urol Onco"},{"key":"key2024100416541800_ref70-bib70","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/jnci\/90.12.925","article-title":"Short-term effects of population-based screening for prostate cancer on health-related quality of life","volume":"90","author":"Essink-Bot","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"key2024100416541800_ref71-bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24370","article-title":"Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT","volume":"24","author":"Hamdy","year":"2020","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref72-bib72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2018.08.007","article-title":"The SmartTarget biopsy trial: a prospective, within-person randomised, blinded trial comparing the accuracy of visual-registration and magnetic resonance imaging\/ultrasound image-fusion targeted biopsies for prostate cancer risk stratification","volume":"75","author":"Hamid","year":"2019","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref73-bib73","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"key2024100416541800_ref74-bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2014.06.013","article-title":"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity biochemical outcome and quality of life","volume":"112","author":"Peters","year":"2014","journal-title":"Radiother Oncol"},{"key":"key2024100416541800_ref75-bib75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.purol.2019.12.006","article-title":"The effect of alpha blocker treatment prior to prostate biopsy on voiding functions, pain scores and health-related quality-of-life outcomes: a prospective randomized trial","volume":"30","author":"Sefik","year":"2020","journal-title":"Prog Urol"},{"key":"key2024100416541800_ref76-bib76","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacr.2018.11.031","article-title":"Temporary health impact of prostate MRI and transrectal prostate biopsy in active surveillance prostate cancer patients","volume":"16","author":"Shankar","year":"2019","journal-title":"J Am Coll Radiol"},{"key":"key2024100416541800_ref77-bib77","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3109\/0284186X.2013.802837","article-title":"Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC)","volume":"52","author":"Vasarainen","year":"2013","journal-title":"Acta Oncol"},{"key":"key2024100416541800_ref78-bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eururo.2012.11.041","article-title":"Health-related quality of life in the Finnish trial of screening for prostate cancer","volume":"65","author":"Booth","year":"2014","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref79-bib79","doi-asserted-by":"crossref","first-page":"e006851","DOI":"10.1136\/bmjopen-2014-006851","article-title":"Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study","volume":"5","author":"Drummond","year":"2015","journal-title":"BMJ Open"},{"key":"key2024100416541800_ref80-bib80","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11136-013-0562-y","article-title":"Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease","volume":"23","author":"Farkkila","year":"2014","journal-title":"Qual Life Res"},{"key":"key2024100416541800_ref81-bib81","doi-asserted-by":"crossref","first-page":"e012952","DOI":"10.1136\/bmjopen-2016-012952","article-title":"Effect of investigation intensity and treatment differences on prostate cancer survivor\u2019s physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study","volume":"6","author":"Gavin","year":"2016","journal-title":"BMJ Open"},{"key":"key2024100416541800_ref82-bib82","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3109\/0284186X.2012.760848","article-title":"Health-related quality of life in prostate cancer","volume":"52","author":"Torvinen","year":"2013","journal-title":"Acta Oncol"},{"key":"key2024100416541800_ref83-bib83","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1111\/bju.13122","article-title":"Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up","volume":"117","author":"Watson","year":"2016","journal-title":"BJU Int"},{"key":"key2024100416541800_ref84-bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19490","article-title":"Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation","volume":"19","author":"Ramsay","year":"2015","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref85-bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.prnil.2020.10.001","article-title":"Rebiopsy rate after transperineal or transrectal prostate biopsy","volume":"9","author":"Marenco Jimenez","year":"2021","journal-title":"Prostate Int"},{"key":"key2024100416541800_ref86-bib86","volume-title":"Apalutamide with Androgen Deprivation Therapy for Treating Hormone-Sensitive Metastatic Prostate Cancer [TA741]","author":"National Institute for Health and Care Excellence","year":"2021"},{"key":"key2024100416541800_ref87-bib87","volume-title":"Enzalutamide for Treating Hormone-Sensitive Metastatic Prostate Cancer Technology Appraisal Guidance [TA712]","author":"National Institute for Health and Care Excellence","year":"2021"},{"key":"key2024100416541800_ref88-bib88","volume-title":"Apalutamide with Androgen Deprivation Therapy for Treating High-risk Hormone-relapsed Non-metastatic Prostate Cancer [TA740]","author":"National Institute for Health and Care Excellence","year":"2021"},{"key":"key2024100416541800_ref89-bib89","volume-title":"Unit Costs of Health and Social Care 2020","author":"Curtis","year":"2020"},{"key":"key2024100416541800_ref90-bib90","volume-title":"2019\/20 National Cost Collection Data Publication","author":"NHS England","year":"2019"},{"key":"key2024100416541800_ref91-bib91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0090-4295(02)02114-3","article-title":"Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial","volume":"61","author":"Kirby","year":"2003","journal-title":"Urology"},{"key":"key2024100416541800_ref93-bib93","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref94-bib94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.15062","article-title":"The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008\u20132019","volume":"126","author":"Tamhankar","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref95-bib95","doi-asserted-by":"crossref","first-page":"d7894","DOI":"10.1136\/bmj.d7894","article-title":"Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study","volume":"344","author":"Rosario","year":"2012","journal-title":"BMJ"},{"key":"key2024100416541800_ref96-bib96","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.urology.2013.02.019","article-title":"Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores","volume":"81","author":"Pepe","year":"2013","journal-title":"Urology"},{"key":"key2024100416541800_ref97-bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bju.15039","article-title":"Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study","volume":"126","author":"Berry","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref98-bib98","doi-asserted-by":"crossref","first-page":"e1002063","DOI":"10.1371\/journal.pmed.1002063","article-title":"Improving clinical risk stratification at diagnosis in primary prostate cancer: a prognostic modelling study","volume":"13","author":"Gnanapragasam","year":"2016","journal-title":"PLOS Med"},{"key":"key2024100416541800_ref99-bib99","doi-asserted-by":"crossref","first-page":"vii1","DOI":"10.3310\/hta17200","article-title":"The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation","volume":"17","author":"Mowatt","year":"2013","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref101-bib101","volume-title":"Drugs and Pharmaceutical Electronic Market Information Tool (eMIT)","author":"Department of Health and Social Care","year":"2020"},{"key":"key2024100416541800_ref102-bib102","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"key2024100416541800_ref103-bib103","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","article-title":"Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial","volume":"387","author":"James","year":"2016","journal-title":"Lancet"},{"key":"key2024100416541800_ref104-bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1903307","article-title":"Apalutamide for metastatic, castration-sensitive prostate cancer","volume":"381","author":"Chi","year":"2019","journal-title":"N Engl J Med"},{"key":"key2024100416541800_ref105-bib105","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol"},{"key":"key2024100416541800_ref106-bib106","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0269216315595203","article-title":"Estimating the cost of caring for people with cancer at the end of life: a modelling study","volume":"29","author":"Round","year":"2015","journal-title":"Palliat Med"},{"key":"key2024100416541800_ref107-bib107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"key2024100416541800_ref108-bib108","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jval.2017.08.3016","article-title":"Cost-effectiveness of antibiotic prophylaxis strategies for transrectal prostate biopsy in an era of increasing antimicrobial resistance","volume":"21","author":"Lee","year":"2018","journal-title":"Value Health"},{"key":"key2024100416541800_ref109-bib109","first-page":"49","article-title":"Evaluation of suspected urinary tract infection in ambulatory women: a cost\u2013utility analysis of office-based strategies","volume":"44","author":"Barry","year":"1997","journal-title":"J Fam Pract"},{"key":"key2024100416541800_ref110-bib110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1524-4733.2001.40202-165.x","article-title":"Observational evaluation of health state utilities among a cohort of sepsis patients","volume":"4","author":"Drabinski","year":"2001","journal-title":"Value Health"},{"key":"key2024100416541800_ref111-bib111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bju.15337","article-title":"Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis","volume":"128","author":"Lopez","year":"2021","journal-title":"BJU Int"},{"key":"key2024100416541800_ref112-bib112","volume-title":"Diagnostic Histopathology Pricing","author":"University of Surrey"},{"key":"key2024100416541800_ref113-bib113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.prnil.2020.10.001","article-title":"Rebiopsy rate after transperineal or transrectal prostate biopsy","volume":"9","author":"Jimenez","year":"2021","journal-title":"Prostate Int"},{"key":"key2024100416541800_ref114-bib114","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1016\/S2666-1683(20)34171-9","article-title":"Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study","volume":"19","author":"Berry","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref115-bib115","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"key2024100416541800_ref116-bib116","first-page":"77","article-title":"P12-1 Readmissions, sepsis and costs of 200,000 NHS prostate biopsies-interrogation of HES data for TRUS vs TP biopsy between 2012\u20132018","volume":"12","author":"Adshead","year":"2019","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref117-bib117","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4111\/kju.2009.50.2.119","article-title":"The comparison between transperineal and transrectal ultrasound-guided prostate needle biopsy","volume":"50","author":"Chae","year":"2009","journal-title":"Korean J Uro"},{"key":"key2024100416541800_ref118-bib118","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1016\/S1569-9056(18)31319-8","article-title":"The role of multi-parametric MRI as a triage test: a propensity-matched comparison of a MRI-triage and a TRUS-biopsy pathway","volume":"17","author":"Eldred-Evans","year":"2018","journal-title":"Eur Urol Suppl"},{"key":"key2024100416541800_ref119-bib119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.pcan.4501004","article-title":"Factors influencing pain during transrectal ultrasonography-guided prostate biopsy","volume":"11","author":"Han","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref120-bib120","doi-asserted-by":"crossref","first-page":"S1327","DOI":"10.1016\/S0302-2838(21)01316-6","article-title":"P0943 \u2013 transrectal and transperineal MRI-guided prostate cancer pathways in biopsy-na\u00efve men","volume":"79","author":"Isra\u00ebl","year":"2021","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref121-bib121","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.urolonc.2014.12.003","article-title":"A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer","volume":"33","author":"Kasivisvanathan","year":"2015","journal-title":"Urol Oncolo Semin Orig Investig"},{"key":"key2024100416541800_ref122-bib122","first-page":"719","article-title":"Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer","volume":"14","author":"Kawakami","year":"2007","journal-title":"Int Jo Urol Off J Jpn Urol Assoc"},{"key":"key2024100416541800_ref123-bib123","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1440-1673.2008.02009.x","article-title":"Transrectal ultrasound and prostate-specific antigen in prostate cancer","volume":"52","author":"Lavoipierre","year":"2008","journal-title":"J Med Imaging Radiat Oncol"},{"key":"key2024100416541800_ref124-bib124","first-page":"7","article-title":"Prospective evaluation of using multi-parametric MRI in cognitive fusion prostate biopsy compared to standard systematic 12-core biopsy in the detection of prostate cancer","volume":"122","author":"Lim","year":"2018","journal-title":"BJU Int"},{"key":"key2024100416541800_ref125-bib125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/UA.UA_98_19","article-title":"Prospective evaluation of using multiparametric magnetic resonance imaging in cognitive fusion prostate biopsy compared to the standard systematic 12-core biopsy in the detection of prostate cancer","volume":"12","author":"Lim","year":"2020","journal-title":"Urol Ann"},{"key":"key2024100416541800_ref126-bib126","first-page":"209","article-title":"Outcomes of transperineal and transrectal ultrasound-guided prostate biopsy","volume":"25","author":"Lo","year":"2019","journal-title":"Hong Kong Med J"},{"key":"key2024100416541800_ref127-bib127","volume-title":"Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections","author":"NCT","year":"2018"},{"key":"key2024100416541800_ref128-bib128","volume-title":"Whether Transperineal Prostate Biopsy Under Local-Anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-na\u00efve Men","author":"NCT","year":"2019"},{"key":"key2024100416541800_ref129-bib129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bju.15092","article-title":"Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?","volume":"126","author":"Neale","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref130-bib130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1148\/radiol.2017162181","article-title":"Cost-effectiveness of MR Imaging-guided strategies for detection of prostate cancer in biopsy-na\u00efve men","volume":"285","author":"Pahwa","year":"2017","journal-title":"Radiology"},{"key":"key2024100416541800_ref131-bib131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.juro.2018.02.072","article-title":"A single center evaluation of the diagnostic accuracy of multiparametric magnetic resonance imaging against transperineal prostate mapping biopsy: an analysis of men with benign histology and insignificant cancer following transrectal ultrasound biopsy","volume":"200","author":"Pal","year":"2018","journal-title":"J Urol"},{"key":"key2024100416541800_ref132-bib132","first-page":"3291","article-title":"Multiparametric MRI\/TRUS fusion prostate biopsy: advantages of a transperineal approach","volume":"37","author":"Pepe","year":"2017","journal-title":"Anticancer Res"},{"key":"key2024100416541800_ref133-bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-017-0213-7","article-title":"The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-na\u00efve men: a prospective, comparative clinical trial using the same patients","volume":"17","author":"Postema","year":"2017","journal-title":"BMC Urol"},{"key":"key2024100416541800_ref134-bib134","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-5347(05)67995-5","article-title":"The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial","volume":"163","author":"Presti","year":"2000","journal-title":"J Urol"},{"key":"key2024100416541800_ref135-bib135","first-page":"528.e15","article-title":"Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template","volume":"36","author":"Ristau","year":"2018","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"key2024100416541800_ref136-bib136","first-page":"99","article-title":"Morbidity and cost implications of shifting from routine transrectal ultrasound-guided prostate biopsy to mpMRI triage with selective transperineal prostate biopsy: a 12-year retrospective analysis from a tertiary referral centre","volume":"125","author":"Roberts","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref137-bib137","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41391-020-0263-x","article-title":"Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution","volume":"24","author":"Roberts","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref138-bib138","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000230016","article-title":"A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores","volume":"83","author":"Rochester","year":"2009","journal-title":"Urol Int"},{"key":"key2024100416541800_ref139-bib139","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/JU.0000000000001083","article-title":"Prostate mapping for cancer diagnosis: the Madrid Protocol. Transperineal prostate biopsies using multiparametric magnetic resonance imaging fusion and micro-ultrasound guided biopsies","volume":"204","author":"Rodriguez Socarras","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref140-bib140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00330-013-3017-5","article-title":"Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR\/TRUS fusion-guided biopsy at 3.0 tesla","volume":"24","author":"Roethke","year":"2014","journal-title":"Eur Radiol"},{"key":"key2024100416541800_ref141-bib141","doi-asserted-by":"crossref","first-page":"e3503","DOI":"10.1016\/S1569-9056(19)34657-3","article-title":"Comparison of cancer detection rates in micro-ultrasound biopsies versus robotic ultrasound-magnetic resonance imaging fusion biopsies for prostate cancer","volume":"18","author":"Rojas Claros","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"key2024100416541800_ref142-bib142","first-page":"15","article-title":"The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience","volume":"72","author":"Salagierski","year":"2019","journal-title":"Cent Eur J Urol"},{"key":"key2024100416541800_ref143-bib143","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.urology.2005.01.051","article-title":"Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy","volume":"66","author":"Satoh","year":"2005","journal-title":"Urology"},{"key":"key2024100416541800_ref144-bib144","first-page":"S130","article-title":"Clinical impact of magnetic resonance imaging (MRI)-guided biopsy on prostate cancer treatment: a single surgeon experience of cognitive-guided and MRI-ultrasound fusion biopsy","volume":"12","author":"Self","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"key2024100416541800_ref145-bib145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1442-2042.2007.01865.x","article-title":"Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men","volume":"14","author":"Shigemura","year":"2007","journal-title":"Int J Urol"},{"key":"key2024100416541800_ref146-bib146","doi-asserted-by":"crossref","first-page":"329.e7","DOI":"10.1016\/j.urolonc.2015.04.005","article-title":"Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy","volume":"33","author":"Sivaraman","year":"2015","journal-title":"Urol Oncol"},{"key":"key2024100416541800_ref147-bib147","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4111\/icu.2019.60.6.454","article-title":"The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy","volume":"60","author":"Song","year":"2019","journal-title":"Investig Clin Urol"},{"key":"key2024100416541800_ref148-bib148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.euo.2018.02.002","article-title":"Not all multiparametric magnetic resonance imaging-targeted bopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer","volume":"1","author":"Stabile","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"key2024100416541800_ref149-bib149","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s101470050084","article-title":"Association between clinical stage of prostate cancer and pathological findings of random systematic transperineal core biopsy under transrectal ultrasonography","volume":"4","author":"Suga","year":"1999","journal-title":"Int J Clin Oncol"},{"key":"key2024100416541800_ref150-bib150","first-page":"165","article-title":"Is our local multi-parametric MRI reliable enough to pave the future for targeted image guided biopsies?","volume":"106","author":"Sulaiman","year":"2019","journal-title":"Br J Surg"},{"key":"key2024100416541800_ref151-bib151","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/pcan.2009.42","article-title":"Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting","volume":"13","author":"Taira","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref152-bib152","first-page":"62","article-title":"P9-7 The clinical and financial implications of a decade of prostate biopsies in the NHS \u2013 interrogation of the Hospital Episode Statistics (HES) Data 2008\u20132019","volume":"13","author":"Tamhankar","year":"2020","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref153-bib153","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00345-015-1711-4","article-title":"Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial","volume":"34","author":"Taverna","year":"2016","journal-title":"World J Urol"},{"key":"key2024100416541800_ref154-bib154","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1016\/j.juro.2016.02.654","article-title":"Endorectal multiparametric 3-tesla magnetic resonance imaging associated to systematic cognitive biopsies do not increase prostate cancer detection rate: a randomized prospective trial","volume":"195","author":"Taverna","year":"2016","journal-title":"J Urol"},{"key":"key2024100416541800_ref155-bib155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4103\/1008-682X.144945","article-title":"Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?","volume":"17","author":"Teoh","year":"2015","journal-title":"Asian J Androl"},{"key":"key2024100416541800_ref156-bib156","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jmri.24770","article-title":"3T MR-guided in-bore transperineal prostate biopsy: a comparison of robotic and manual needle-guidance templates","volume":"42","author":"Tilak","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"key2024100416541800_ref157-bib157","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.euf.2020.06.020","article-title":"Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging\/transrectal ultrasonography-fusion biopsy","volume":"7","author":"Tschirdewahn","year":"2021","journal-title":"Eur Urol Focus"},{"key":"key2024100416541800_ref158-bib158","first-page":"424.e9","article-title":"Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer","volume":"33","author":"Valerio","year":"2015","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"key2024100416541800_ref159-bib159","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/S1677-55382004000200005","article-title":"Is the periprostatic anesthetic blockade advantageous in ultrasound-guided prostate biopsy?","volume":"30","author":"Vanni","year":"2004","journal-title":"Int Braz J Urol"},{"key":"key2024100416541800_ref160-bib160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/medicina57010057","article-title":"Systematic and MRI-cognitive targeted transperineal prostate biopsy accuracy in detecting clinically significant prostate cancer after previous negative biopsy and persisting suspicion of malignancy","volume":"57","author":"Vezelis","year":"2021","journal-title":"Medicina"},{"key":"key2024100416541800_ref161-bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-019-0535-8","article-title":"Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Urol"},{"key":"key2024100416541800_ref162-bib162","first-page":"678","article-title":"Systematic prostate biopsy still matters: a comprehensive analysis of MRI\/TRUS-fusion targeted prostate biopsies across different indications","volume":"37","author":"Westhoff","year":"2019","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"key2024100416541800_ref163-bib163","first-page":"52","article-title":"A retrospective analysis of transperineal cognitive fusion biopsy of high grade multi-parametric MRI lesions (PIRADS 4-5) in helping to detect clinically significant prostate cancer lesions","volume":"14","author":"Williams","year":"2018","journal-title":"Asia-Pac J Clin Oncol"},{"key":"key2024100416541800_ref164-bib164","first-page":"51","article-title":"Multi-parametric magnetic resonance imaging (MPMRI) in detecting prostate cancer: an initial experience in a tertiary centre","volume":"14","author":"Williams","year":"2018","journal-title":"Asia-Pac J Clin Oncol"},{"key":"key2024100416541800_ref165-bib165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/iju.14127","article-title":"Magnetic resonance imaging-guided targeted prostate biopsy: comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-na\u00efve patients","volume":"27","author":"Yamada","year":"2020","journal-title":"Int J Urol"},{"key":"key2024100416541800_ref166-bib166","first-page":"157","article-title":"Introducing PrecisionPoint TM transperineal biopsy into a district general hospital: a viable alternative to TRUS and templates?","volume":"106","author":"Yang","year":"2019","journal-title":"Br J Surg"},{"key":"key2024100416541800_ref167-bib167","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bju.13971","article-title":"Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions","volume":"120","author":"Yaxley","year":"2017","journal-title":"BJU Int"},{"key":"key2024100416541800_ref168-bib168","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clinimag.2009.02.003","article-title":"Are transition zone biopsies necessary in transrectal ultrasound-guided transperineal prostate biopsy protocol? Results of a Chinese population-based study","volume":"34","author":"Yunkai","year":"2010","journal-title":"Clin Imaging"},{"key":"key2024100416541800_ref169-bib169","doi-asserted-by":"crossref","first-page":"243","DOI":"10.21037\/tau.2020.02.20","article-title":"Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for na\u00efve biopsy patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl Androl Urol"},{"key":"key2024100416541800_ref170-bib170","first-page":"82","article-title":"Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for na\u00efve biopsy patients","volume":"26","author":"Zhang","year":"2019","journal-title":"Int J Urol"},{"key":"key2024100416541800_ref171-bib171","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11255-016-1484-8","article-title":"Comparison of free-hand transperineal mpMRI\/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China","volume":"49","author":"Zhang","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"key2024100416541800_ref172-bib172","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11255-015-0957-5","article-title":"Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China","volume":"47","author":"Zhang","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"key2024100416541800_ref173-bib173","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1259\/bjr\/68418881","article-title":"Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results","volume":"85","author":"Zhao","year":"2012","journal-title":"Br J Radiol"},{"key":"key2024100416541800_ref174-bib174","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JU.0000000000000587","article-title":"Prostate cancer detection rate of freehand versus 3-dimensional template mapping biopsy using a magnetic resonance imaging-ultrasound fusion device in biopsy na\u00efve men","volume":"203","author":"Zhou","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref175-bib175","first-page":"156","article-title":"Freehand transperineal ultrasound guided biopsy of the prostate under local anaesthetic: a cost effective and viable diagnostic procedure for prostate cancer?","volume":"106","author":"Al-Dhahir","year":"2019","journal-title":"Br J Surg"},{"key":"key2024100416541800_ref176-bib176","doi-asserted-by":"crossref","first-page":"e2305","DOI":"10.1016\/S2666-1683(20)34166-5","article-title":"PT432 - Road to Trexit: a territory-wide study on the predictors of 30-day complications in transrectal versus transperineal prostate biopsy","volume":"19","author":"Chan","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref177-bib177","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/JU.0000000000000961.07","article-title":"MP75-07 A territory-wide study on the predictors of 30-day complications in transrectal versus transperineal prostate biopsy","volume":"203","author":"Chan","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref178-bib178","first-page":"e267","article-title":"MI trexit: pilot evaluation of a state-wide initiative for in-office transperineal versus transrectal prostate biopsy under local anesthesia","volume":"201","author":"Cole","year":"2019","journal-title":"J Urol"},{"key":"key2024100416541800_ref179-bib179","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1097\/JU.0000000000000927.018","article-title":"MP58-18 Transrectal MRI\/US fusion biopsy doubles the risk of infectious hospitalization \u2013 analysis of a statewide collaboratives","volume":"203","author":"Cole","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref180-bib180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1569-9056(18)33305-0","article-title":"P211 \u2013 Detection of prostate cancer: Comparison between \u2018In-bore\u2019 MRI-guided biopsies and cognitive transperineal-ultrasound-guided biopsies","volume":"17","author":"Demozzi","year":"2018","journal-title":"Eur Urol Suppl"},{"key":"key2024100416541800_ref181-bib181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4081\/aiua.2017.1.55","article-title":"A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer","volume":"89","author":"Di Franco","year":"2017","journal-title":"Arch Ital Urol Androl"},{"key":"key2024100416541800_ref182-bib182","doi-asserted-by":"crossref","first-page":"e2310","DOI":"10.1016\/S2666-1683(20)34170-7","article-title":"PT436: Transperineal template biopsy is both safer and more cost-effective than transrectal ultrasound-guided prostate biopsy in the Australian public hospital setting","volume":"19","author":"Elkhoury","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref183-bib183","first-page":"e307","article-title":"MP20-03 Patient experience for transperineal biopsy under local anesthesia versus transrectal biopsy: results from the Michigan Urological Surgery Improvement Collaborative","volume":"203","author":"Ferrante","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref184-bib184","first-page":"e514","article-title":"MP36-02 Periprocedural and diagnostic outcomes of transrectal versus transperineal US\/MRI guided fusion prostate biopsy: multi-institutional propensity score matched pair analysis","volume":"201","author":"Ferriero","year":"2019","journal-title":"J Urol"},{"key":"key2024100416541800_ref185-bib185","first-page":"e309","article-title":"MP20-06 A comparison of infectious outcomes between in-office transperineal prostate biopsies without antibiotic prophylaxis and transrectal prostate biopsies","volume":"203","author":"Islam","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref186-bib186","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1097\/JU.0000000000002111.09","article-title":"V14-09 Infectious outcomes between in-office transperineal prostate biopsies without antibiotic prophylaxis and transrectal prostate biopsies","volume":"206","author":"Islam","year":"2021","journal-title":"J Urol"},{"key":"key2024100416541800_ref187-bib187","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/JU.0000000000002002.14","article-title":"MP17-14 Cost-effectiveness of transperineal versus transrectal prostate biopsy for the diagnosis of prostate cancer","volume":"206","author":"Lai","year":"2021","journal-title":"J Urol"},{"key":"key2024100416541800_ref188-bib188","first-page":"38","article-title":"P5-4 Comparison of TRUS-biopsy to transperineal template mapping biopsies stratified by MRI score within the PROMIS trial","volume":"12","author":"Lovegrove","year":"2019","journal-title":"J Clin Urol"},{"key":"key2024100416541800_ref189-bib189","first-page":"e425","article-title":"MP30-08 Comparison of TRUS-biopsy to transperineal template mapping biopsies stratified by MRI score within the PROMIS trial","volume":"201","author":"Lovegrove","year":"2019","journal-title":"J Urol"},{"key":"key2024100416541800_ref190-bib190","first-page":"61","article-title":"Concordance of transperineal, transrectal and transperineal sector-based template approaches with 305 radical prostatectomies: a multicentre study","volume":"115","author":"Marra","year":"2015","journal-title":"BJU International Conference: 71st annual scientific meeting of the British Association of Urological Surgeons, BAUS 2015 United Kingdom"},{"key":"key2024100416541800_ref191-bib191","first-page":"e804","article-title":"PD38-08 Multi-institutional prospective validation of the novel Michigan urological surgery improvement collaborative transperineal biopsy template","volume":"203","author":"Maruf","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref192-bib192","doi-asserted-by":"crossref","first-page":"e2312","DOI":"10.1016\/S2666-1683(20)34172-0","article-title":"PT438 \u2013 a switch from transrectal biopsy to cognitive freehand transperineal prostate biopsy can reduce sepsis where targeted antibiotics for resistant rectal flora have failed","volume":"19","author":"Newman","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"key2024100416541800_ref193-bib193","first-page":"6","article-title":"Zero sepsis rate: a new era of transperineal ultrasound-guided prostate biopsy","volume":"123","author":"Ng","year":"2019","journal-title":"BJU Int"},{"key":"key2024100416541800_ref194-bib194","doi-asserted-by":"crossref","first-page":"e2550","DOI":"10.1016\/S1569-9056(19)32653-3","article-title":"Post-MRI primary local anaesthetic freehand transperineal prostate biopsy significantly reduces biopsy rate in comparison to trans-rectal prostate biopsy: implications for service burden in a secondary-care referral centre in Northern Ireland","volume":"18","author":"Sharma","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"key2024100416541800_ref195-bib195","first-page":"e1181","article-title":"PD64-03 TREXIT \u2013 a year on. Making a clean break from trans-rectal prostate biopsy","volume":"201","author":"Stroman","year":"2019","journal-title":"J Urol"},{"key":"key2024100416541800_ref196-bib196","first-page":"e1241","article-title":"MP81-14 Local anesthetic, intravenous sedation or general anesthetic freehand guided transperineal prostate biopsies: does anesthetic modality impact cancer detection and adverse events?","volume":"203","author":"Stroman","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref197-bib197","first-page":"e1243","article-title":"MP81-18 A switch from transrectal biopsy to cognitive freehand transperineal prostate biopsy can reduce sepsis where targeted antibiotics for resistant rectal flora have failed","volume":"203","author":"Stroman","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref198-bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3794738","article-title":"Assessment of the performance of magnetic resonance imaging\/ultrasound fusion guided prostate biopsy against a combined targeted plus systematic biopsy approach using 24-core transperineal template saturation mapping prostate biopsy","volume":"2016","author":"Ting","year":"2016","journal-title":"Prostate Cancer"},{"key":"key2024100416541800_ref199-bib199","first-page":"e1237","article-title":"Comparative outcomes of 2 different transperineal prostate biopsy techniques","volume":"203","author":"Urkmez","year":"2020","journal-title":"J Urol"},{"key":"key2024100416541800_ref200-bib200","first-page":"e1003","article-title":"PD56-01 Freehand versus grid-based transperineal prostate biopsy: a comparison of anatomic region yield and complications","volume":"206","author":"Urkmez","year":"2021","journal-title":"J Urol"},{"key":"key2024100416541800_ref201-bib201","doi-asserted-by":"crossref","first-page":"S1348","DOI":"10.1016\/S0302-2838(21)01331-2","article-title":"P0958: transperineal vs. transrectal MRI-targeted prostate biopsy: evaluation of cancer detection risk and biopsy accuracy for clinical significant prostate cancer","volume":"79","author":"Zattoni","year":"2021","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref202-bib202","volume-title":"Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-Effectiveness Analysis","author":"NCT","year":"2020"},{"key":"key2024100416541800_ref203-bib203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41391-018-0056-7","article-title":"Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research","volume":"21","author":"Altok","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref204-bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-021-06916-0","article-title":"Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore","volume":"21","author":"Cheng","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"key2024100416541800_ref205-bib205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urology.2021.06.023","article-title":"Comparative effectiveness and tolerability of transperineal MRI-targeted prostate biopsy under local versus sedation","volume":"155","author":"Cricco-Lizza","year":"2021","journal-title":"Urology"},{"key":"key2024100416541800_ref206-bib206","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bju.15120","article-title":"Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthetic transperineal biopsy","volume":"126","author":"Popert","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref207-bib207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19870","article-title":"The clinical effectiveness and cost-effectiveness of the PROGENSA\u00ae prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation","volume":"19","author":"Nicholson","year":"2015","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref208-bib208","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.urolonc.2015.09.010","article-title":"Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer","volume":"34","author":"Cerantola","year":"2016","journal-title":"Urol Oncol"},{"key":"key2024100416541800_ref209-bib209","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2013.12.012","article-title":"Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective","volume":"66","author":"de Rooij","year":"2014","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref210-bib210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bju.13861","article-title":"Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics \u2013 a decision analytical model","volume":"120","author":"Dijkstra","year":"2017","journal-title":"BJU Int"},{"key":"key2024100416541800_ref211-bib211","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jval.2021.06.001","article-title":"Cost-effectiveness of magnetic resonance imaging in prostate cancer screening: a microsimulation study","volume":"24","author":"Hao","year":"2021","journal-title":"Value Health"},{"key":"key2024100416541800_ref212-bib212","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.euo.2018.05.007","article-title":"The role of multiparametric magnetic resonance imaging in active surveillance for men with low-risk prostate cancer: a cost-effectiveness modeling study","volume":"1","author":"Patel","year":"2018","journal-title":"Eur Urol ogy"},{"key":"key2024100416541800_ref213-bib213","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/bju.14617","article-title":"A clinical prediction tool to determine the need for concurrent systematic sampling at the time of magnetic resonance imaging-guided biopsy","volume":"123","author":"Sathianathen","year":"2019","journal-title":"BJU Int"},{"key":"key2024100416541800_ref214-bib214","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2214\/AJR.16.17322","article-title":"Cost-effectiveness comparison of imaging-guided prostate biopsy techniques: systematic transrectal ultrasound, direct in-bore MRI, and image fusion","volume":"208","author":"Venderink","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"key2024100416541800_ref215-bib215","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.juro.2010.11.079","article-title":"Focal therapy for localized prostate cancer: a phase I\/II trial","volume":"185","author":"Ahmed","year":"2011","journal-title":"J Urol"},{"key":"key2024100416541800_ref216-bib216","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.urology.2013.11.002","article-title":"Association of prostate volume with voiding impairment and deterioration in quality of life after prostate biopsy","volume":"83","author":"Aktas","year":"2014","journal-title":"Urology"},{"key":"key2024100416541800_ref217-bib217","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/pcan.2008.21","article-title":"The measurement of psychological distress in men being investigated for the presence of prostate cancer","volume":"11","author":"Awsare","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key2024100416541800_ref218-bib218","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bju.12265","article-title":"TOOKAD Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer","volume":"112","author":"Azzouzi","year":"2013","journal-title":"BJU Int"},{"key":"key2024100416541800_ref219-bib219","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/JU.0000000000000024","article-title":"Impact of subsequent biopsies on comprehensive health related quality of life in patients with and without prostate cancer","volume":"201","author":"Burns","year":"2019","journal-title":"J Urol"},{"key":"key2024100416541800_ref220-bib220","first-page":"33","article-title":"Prostate cancer screening: a decision analysis","volume":"41","author":"Cantor","year":"1995","journal-title":"J Fam Pract"},{"key":"key2024100416541800_ref221-bib221","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/089277901300189501","article-title":"Results and side effects of high-intensity focused ultrasound in localized prostate cancer","volume":"15","author":"Chaussy","year":"2001","journal-title":"J Endourol"},{"key":"key2024100416541800_ref222-bib222","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cct.2013.06.005","article-title":"A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: the INDEX study","volume":"36","author":"Dickinson","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"key2024100416541800_ref223-bib223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7140","article-title":"Prostate testing for cancer and treatment (ProtecT) feasibility study","volume":"7","author":"Donovan","year":"2003","journal-title":"Health Technol Assess"},{"key":"key2024100416541800_ref224-bib224","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.eururo.2020.05.010","article-title":"Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise on oncologic efficacy: single-surgeon series and step-by-step guide","volume":"79","author":"Egan","year":"2021","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref225-bib225","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.juro.2017.10.033","article-title":"Prospective multicenter phase II study on focal therapy (hemiablation) of the prostate with high intensity focused ultrasound","volume":"199","author":"Ganzer","year":"2018","journal-title":"J Urol"},{"key":"key2024100416541800_ref226-bib226","doi-asserted-by":"crossref","first-page":"W177","DOI":"10.2214\/AJR.14.13098","article-title":"Real-time MRI-guided focused ultrasound for focal therapy of locally confined low-risk prostate cancer: feasibility and preliminary outcomes","volume":"205","author":"Ghai","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"key2024100416541800_ref227-bib227","first-page":"6282","article-title":"Prostate calculi can higher urinary retention probability and worsen uncomfortable feeling after prostate biopsy but not predict cancer","volume":"8","author":"Gu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key2024100416541800_ref228-bib228","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.juro.2007.08.014","article-title":"Phase I\/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer","volume":"178","author":"Koch","year":"2007","journal-title":"J Urol"},{"key":"key2024100416541800_ref229-bib229","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eururo.2006.03.024","article-title":"Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men","volume":"50","author":"Kok","year":"2006","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref230-bib230","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1814::AID-CNCR20>3.0.CO;2-7","article-title":"Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project","volume":"80","author":"Mettlin","year":"1997","journal-title":"Cancer"},{"key":"key2024100416541800_ref231-bib231","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/1471-2407-10-572","article-title":"Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial","volume":"10","author":"Miki","year":"2010","journal-title":"BMC Cancer"},{"key":"key2024100416541800_ref232-bib232","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2015.12.083","article-title":"Focal laser ablation of prostate cancer: phase I clinical trial","volume":"196","author":"Natarajan","year":"2016","journal-title":"J Urol"},{"key":"key2024100416541800_ref233-bib233","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005392-200101000-00025","article-title":"Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores","volume":"165","author":"Naughton","year":"2001","journal-title":"J Urol"},{"key":"key2024100416541800_ref234-bib234","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12894-020-00718-y","article-title":"Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol","volume":"21","author":"Pane-Alemany","year":"2021","journal-title":"BMC Urol"},{"key":"key2024100416541800_ref235-bib235","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-5347(01)65084-5","article-title":"The efficacy and complications of salvage cryotherapy of the prostate","volume":"157","author":"Pisters","year":"1997","journal-title":"J Urol"},{"key":"key2024100416541800_ref236-bib236","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2010.08.027","article-title":"Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment","volume":"58","author":"Soloway","year":"2010","journal-title":"Eur Urol"},{"key":"key2024100416541800_ref237-bib237","first-page":"651","article-title":"Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study","volume":"51","author":"Uchida","year":"2005","journal-title":"Acta Urol Jpn"},{"key":"key2024100416541800_ref238-bib238","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cct.2014.07.006","article-title":"A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT)","volume":"39","author":"Valerio","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"key2024100416541800_ref239-bib239","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrurol.2013.179","article-title":"Prostate cancer: MRI\/US-guided biopsy: a viable alternative to TRUS-guidance","volume":"10","author":"Van De Ven","year":"2013","journal-title":"Nat Rev Urol"},{"key":"key2024100416541800_ref240-bib240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0272989X06290496","article-title":"Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decis Making"},{"key":"key2024100416541800_ref241-bib241","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","article-title":"Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available)","volume":"11","author":"Ara","year":"2008","journal-title":"Value Health"},{"key":"key2024100416541800_ref242-bib242","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bju.14182","article-title":"Urinary, bowel and sexual health in older men from Northern Ireland","volume":"122","author":"Donnelly","year":"2018","journal-title":"BJU Int"},{"key":"key2024100416541800_ref243-bib243","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","article-title":"Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study","volume":"20","author":"Downing","year":"2019","journal-title":"Lancet Oncol"},{"key":"key2024100416541800_ref244-bib244","doi-asserted-by":"crossref","first-page":"e002317","DOI":"10.1136\/bmjopen-2012-002317","article-title":"Patient-reported outcomes of cancer survivors in England 1\u20135 years after diagnosis: a cross-sectional survey","volume":"3","author":"Glaser","year":"2013","journal-title":"BMJ Open"},{"key":"key2024100416541800_ref245-bib245","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.clgc.2019.11.015","article-title":"Health-related quality of life and pain in a real-world castration-resistant prostate cancer population: results from the PRO-CAPRI study in the Netherlands","volume":"18","author":"Kuppen","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"key2024100416541800_ref246-bib246","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00520-021-06404-5","article-title":"Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment","volume":"30","author":"Lemanska","year":"2022","journal-title":"Support Care Cancer"},{"key":"key2024100416541800_ref247-bib247","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jval.2015.08.012","article-title":"Health-related quality of life and health utilities in metastatic castrate-resistant prostate cancer: a survey capturing experiences from a diverse sample of UK patients","volume":"18","author":"Lloyd","year":"2015","journal-title":"Value Health"},{"key":"key2024100416541800_ref248-bib248","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21037\/tau.2017.03.80","article-title":"Health state utilities among contemporary prostate cancer patients on active surveillance","volume":"7","author":"Loeb","year":"2018","journal-title":"Transl Androl Urol"},{"key":"key2024100416541800_ref249-bib249","first-page":"368","article-title":"Impact of locally advanced or metastatic prostate cancer on the quality of life","volume":"41","author":"Lopez-Calderero","year":"2017","journal-title":"Actas Urol Esp"},{"key":"key2024100416541800_ref250-bib250","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00520-018-4633-z","article-title":"Problems sleeping with prostate cancer: exploring possible risk factors for sleep disturbance in a population-based sample of survivors","volume":"27","author":"Maguire","year":"2019","journal-title":"Support Care Cancer"},{"key":"key2024100416541800_ref251-bib251","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s11136-019-02184-y","article-title":"Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P","volume":"28","author":"Murasawa","year":"2019","journal-title":"Qual Life Res"},{"key":"key2024100416541800_ref252-bib252","doi-asserted-by":"crossref","first-page":"101830","DOI":"10.1016\/j.canep.2020.101830","article-title":"Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: a population-based study","volume":"69","author":"Smith","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"key2024100416541800_ref253-bib253","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bju.14980","article-title":"United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia","volume":"125","author":"Uemura","year":"2020","journal-title":"BJU Int"},{"key":"key2024100416541800_ref254-bib254","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.euf.2020.11.002","article-title":"Europa Uomo Patient Reported Outcome Study (EUPROMS): descriptive statistics of a prostate cancer survey from patients for patients","volume":"7","author":"Venderbos","year":"2021","journal-title":"Eur Urol Focus"},{"key":"key2024100416541800_ref255-bib255","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pon.5362","article-title":"Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: a population-based patient-reported outcome study","volume":"29","author":"Wilding","year":"2020","journal-title":"Psychooncology"},{"key":"key2024100416541800_ref256-bib256","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.21037\/tau-20-689","article-title":"Baseline patient reported outcomes data shows high prevalence of overactive bladder, sexual dysfunction, depression and anxiety in Canadian men with newly diagnosed localized prostate cancer","volume":"9","author":"Yao","year":"2020","journal-title":"Transl Androl Urol"},{"key":"key2024100416541800_ref258-bib258","first-page":"225","article-title":"Duration of treatment in prostate cancer patients treated with abiraterone acetate or enzalutamide","volume":"23","author":"Pilon","year":"2017","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2046268","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/ZKTW8214\/ZKTW8214.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2046268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:35:24Z","timestamp":1728041724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/ZKTW8214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":248,"alternative-id":["10.3310\/ZKTW8214"],"URL":"https:\/\/doi.org\/10.3310\/zktw8214","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"06-2021","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"12-2021","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"12-2022","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}